Structural basis for the activity of the RSK-specific inhibitor, SL0101

…, DJ Maloney, SM Hecht, DA Lannigan

文献索引：Smith, Jeffrey A.; Maloney, David J.; Hecht, Sidney M.; Lannigan, Deborah A. Bioorganic and Medicinal Chemistry, 2007 , vol. 15, # 14 p. 5018 - 5034

全文：HTML全文

被引用次数: 49

摘要

Inappropriate activity of p90 ribosomal S6 kinase (RSK) has been implicated in various human cancers as well as other pathologies. We previously reported the isolation, characterization, and synthesis of the natural product kaempferol 3-O-(3 ″, 4 ″-di-O-acetyl- α-l-rhamnopyranoside), termed SL0101 [Smith, JA; Poteet-Smith, CE; Xu, Y.; Errington, TM; Hecht, SM; Lannigan, DA Cancer Res., 2005, 65, 1027–1034: Xu, Y.-M; Smith, JA; ...